Literature DB >> 3579390

Systemic lupus erythematosus, pulmonary hypertension, and left recurrent laryngeal nerve palsy.

O M Aszkenasy, T J Clarke, P Hickling, A J Marshall.   

Abstract

Pulmonary hypertension in systemic lupus erythematosus (SLE) is rare in the absence of parenchymal lung disease. We report such a case, which was complicated by the subsequent development of a left recurrent laryngeal nerve palsy, and in which there was a strong family history of SLE.

Entities:  

Mesh:

Year:  1987        PMID: 3579390      PMCID: PMC1002109          DOI: 10.1136/ard.46.3.246

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  4 in total

1.  Pulmonary hypertension in systemic lupus erythematosus.

Authors:  R A Asherson; C G Mackworth-Young; M L Boey; R G Hull; A Saunders; A E Gharavi; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-08

Review 2.  Studies in familial systemic lupus erythematosus.

Authors:  F C Arnett; L E Shulman
Journal:  Medicine (Baltimore)       Date:  1976-07       Impact factor: 1.889

3.  Left vocal cord paralysis and dysphagia in mitral valve disease.

Authors:  A A Morgan; A J Mourant
Journal:  Br Heart J       Date:  1980-04

Review 4.  Pulmonary hypertension in systemic lupus erythematosus: report of four cases and review of the literature.

Authors:  H D Perez; N Kramer
Journal:  Semin Arthritis Rheum       Date:  1981-08       Impact factor: 5.532

  4 in total
  3 in total

1.  Laryngeal involvement as a presenting symptom of systemic lupus erythematosus.

Authors:  A Kraus; G Guerra-Bautista
Journal:  Ann Rheum Dis       Date:  1990-06       Impact factor: 19.103

Review 2.  Compression of adjacent anatomical structures by pulmonary artery dilation.

Authors:  Wael Dakkak; Adriano R Tonelli
Journal:  Postgrad Med       Date:  2016-03-07       Impact factor: 3.840

3.  Primary pulmonary hypertension associated with systemic lupus erythematosus.

Authors:  A Turner; A Samanta; F E Nichol
Journal:  Clin Rheumatol       Date:  1991-09       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.